ongoing projects

2024: 

1. DST SERB CRG (INR 46,19,918) PI: Dr. Arpitha Anantharaju, JIPMER, Co-PI: Dr. Uttam M. Pal, Co-PI: Dr. Sreekumaran Nair, JIPMER, Co-PI: Dr. Murali S, Status: Under implementation, Project title: Development of bi-modal transvaginal probe and evaluation of its diagnostic accuracy for a non-invasive AI-based detection of pre-invasive cervical lesion in comparison to standard colposcopy in screen positive patients.

2023: 

1. ICMR Small Investigator Initiated Call (INR 1,03,38,015) PI: Dr. Arpitha Anantharaju, JIPMER, Co-PI: Dr. Uttam M. Pal, Co-PI: Dr. Sreekumaran Nair, JIPMER, Co-PI: Dr. Murali S, Co-PI: Dr. Hardik J. Pandya, Status: Approved Project title: Opto-electrical transvaginal imaging probe for preinvasive cervical cancer diagnosis

2. DBT Call for Proposal on Biomedical Devices (INR 71,82,000), PI: Dr. Hardik J. Pandya, IISc Bangalore, Co-PI: Gayatri Gogoi, Assam Medical College, Co-PI: Dr. Uttam M. Pal. Status: Approved, Project Title: Design and Development of a bimodal intraoperative probe for breast cancer diagnosis.

3. Support for Major Interdisciplinary Research Equipment S.M.I.R.E, 2023 (INR60,00,000), PI: Dr. Gowri, Co-PI: Dr. Uttam M. Pal, Co-PI: Dr. Naveen Kumar, Status: Ongoing, Project Title: Raman Spectrometer Bundle.

4. DST SERB ACCELERATE VIGYAN VRITIKA Scheme Project funding (Rs. 1,50,000) PI: Dr. Uttam M. Pal, Proejct Title: "Design and Development of Ring-Collection based Spatially Offset Raman Spectroscopy (SORSDx) for Rapid Breast Cancer Margin Assessment using ex-vivo tissues samples", 2023. Status: Completed. 

5. Institute SEED Grant (IIITDM Kancheepuram)(INR 6,50,000) PI: Dr. Uttam M. Pal, Status: Ongoing, Project Title: Design and Development of real time Diffuse Reflectance Spectroscopy (rt-DRS) Probe for Intraoperative Tumour Margin Assessment during Breast Conservation Surgery.

2022:

1. DST SERB ACCELERATE VIGYAN VRITIKA Scheme Project funding (Rs. 60,0000) PI: Dr. Uttam M. Pal, Project Title: "A mobile camera-based Raman Spectroscopy device to study the molecular signature of breast cancer tissues ", 2022.